Get the Stockscreener App
35.46
0.34%
0.12
After Hours:
37.23
1.77
+4.99%
Vericel Corp stock is traded at $35.46, with a volume of 610.38K.
It is up +0.34% in the last 24 hours and down -15.61% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$35.34
Open:
$35.51
24h Volume:
610.38K
Relative Volume:
1.19
Market Cap:
$1.79B
Revenue:
$226.84M
Net Income/Loss:
$3.55M
P/E Ratio:
506.57
EPS:
0.07
Net Cash Flow:
$-12.02M
1W Performance:
-10.95%
1M Performance:
-15.61%
6M Performance:
-40.46%
1Y Performance:
-29.24%
1-Day Range:
$34.87
$36.05
1-Week Range:
$34.87
$39.95
52-Week Range:
$34.87
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
35.46 | 2.00B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Vericel Corporation Stock Analysis and ForecastFree Consultation - Autocar Professional
Bank of New York Mellon Corp Sells 9,409 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
What drives Vericel Corporation stock priceFree Expert Stock Watchlist - Autocar Professional
Nisa Investment Advisors LLC Sells 315 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Cerity Partners LLC Boosts Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
Is Vericel Corporation a good long term investmentFastest-growing stock picks - Jammu Links News
Is Vericel Corporation stock overhyped or has real potential2x 3x 5x Pick Alert - Newser
How high can Vericel Corporation stock price go in 20252x Return Forecast - Newser
What institutions are buying Vericel Corporation stock nowVerified Return Tips - newser.com
Vericel Corporation to Report Second-Quarter 2025 Financial Results on July 31, 2025 - Quiver Quantitative
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Teacher Retirement System of Texas - Defense World
Vericel stock hits 52-week low at $37.38 amid market challenges - Investing.com Nigeria
Vericel stock hits 52-week low at $37.38 amid market challenges By Investing.com - Investing.com South Africa
What makes Vericel Corporation stock price move sharplyFree Stock Movement Tracking - Newser
Why Vericel Corporation stock attracts strong analyst attentionReal Trader Insights - Newser
Vericel stock maintains Buy rating at BTIG despite potential competition - Investing.com
Principal Financial Group Inc. Buys 7,222 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Amalgamated Bank Reduces Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
New York State Teachers Retirement System Decreases Stock Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
GAMMA Investing LLC Has $129,000 Holdings in Vericel Corporation (NASDAQ:VCEL) - Defense World
Vericel Corporation (NASDAQ:VCEL) Receives $61.14 Consensus Price Target from Analysts - Defense World
Vericel Corporation(NasdaqGM: VCEL) added to Russell 2000 Defensive Index - MarketScreener
Is Vericel Corp. overvalued or undervalued? - MarketsMojo
If EPS Growth Is Important To You, Vericel (NASDAQ:VCEL) Presents An Opportunity - Yahoo Finance
Vericel at 2025 Truist Securities MedTech Conference: Growth Strategies Unveiled - Investing.com India
Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens - Defense World
Vericel (VCEL): Analyst Reiterates Overweight Rating with Stable Price Target | VCEL Stock News - GuruFocus
Handelsbanken Fonder AB Has $914,000 Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Rhumbline Advisers - Defense World
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 - Yahoo Finance
GAMMA Investing LLC Acquires 127,028 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Analysts - Defense World
3,924 Shares in Vericel Co. (NASDAQ:VCEL) Bought by Mackenzie Financial Corp - Defense World
Canaccord Genuity reiterates Buy rating on Vericel stock with $61 target - Investing.com
Bank of America Corp DE Sells 1,579 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel’s (VCEL) Overweight Rating Reiterated at Stephens - Defense World
What Analysts Are Saying About Vericel Stock - Benzinga
Vericel (VCEL) Maintains Overweight Rating by Stephens & Co. | V - GuruFocus
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Deutsche Bank AG - Defense World
Vericel Co. (NASDAQ:VCEL) Stock Position Cut by BNP Paribas Financial Markets - Defense World
Truist maintains Buy on Vericel shares with $52 target By Investing.com - Investing.com India
Truist maintains Buy on Vericel shares with $52 target - Investing.com
VCEL to Be Featured in Upcoming Investor Meetings | VCEL Stock N - GuruFocus
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $60.86 - Defense World
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare By Investing.com - Investing.com India
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare - Investing.com Australia
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):